Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Beneficial impact of a clinical care pathway in patients with testicular cancer undergoing retroperitoneal lymph node dissection.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Beneficial impact of a clinical care pathway in patients with testicular cancer undergoing retroperitoneal lymph node dissection.
Beneficial impact of a clinical care pathway in patients with testicular cancer undergoing retroperitoneal lymph node dissection. J Urol. 2002 Jul; 168(1):87-92.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Chemotherapy, Adjuvant
Chemotherapy, Adjuvant
Critical Pathways
Critical Pathways
Follow-Up Studies
Follow-Up Studies
Humans
Humans
Length of Stay
Length of Stay
Lymph Node Excision
Lymph Node Excision
Male
Male
Middle Aged
Middle Aged
Neoadjuvant Therapy
Neoadjuvant Therapy
Neoplasm Staging
Neoplasm Staging
Neoplasms, Germ Cell and Embryonal
Neoplasms, Germ Cell and Embryonal
Postoperative Complications
Postoperative Complications
Retroperitoneal Space
Retroperitoneal Space
Testicular Neoplasms
Testicular Neoplasms
authors with profiles
Michael S Cookson